(Q72012065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

A randomised trial of two cisplatin-containing chemotherapy regimens in patients with stage III-B and IV non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

22 July 2024

1 reference

non-small-cell lung carcinoma

1 reference

M. Erkisi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655833

22 July 2024

F. Doran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655833

22 July 2024

R. Burgut

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655833

22 July 2024

A. Kocabas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7655833

22 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7655833

22 July 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.elsevier.com/content/article/PII:0169500295004479?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

https://api.elsevier.com/content/article/PII:0169500295004479?httpAccept=text/plain

22 July 2024

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

22 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

237-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

Etoposide in the management of non-small cell lung cancer

22 October 2019

uses

randomized experiment

0 references

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer

22 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer

22 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study

22 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin

22 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study

22 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

A new international staging system for lung cancer

22 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer

22 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

MICE: a new active combination for non-small cell lung cancer

22 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study

22 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

Alternating chemotherapy in advanced non-small cell lung cancer: a phase II study.

22 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0169-5002(95)00447-9

22 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7655833%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference